Clinical epidemiology of cardiovascular disease in chronic kidney disease.

作者: Robert N. Foley

DOI: 10.1111/J.1755-6686.2010.00171.X

关键词:

摘要: The public health importance of chronic kidney disease (CKD) has only come to be appreciated in the last decade. While glomerular filtration rate (GFR) and urinary albumin creatinine levels are highly predictive mortality, thresholds that may useful for screening much closer 'normal' than generally recognised. When optimising balance between true negative positive mortality prediction, GFR from cystatin C ratios all seem perform similarly. Among older population, rates with creatinine-based lowest those 60 90 ml/min/1.73 m(2), unlike C, where climb monotonically declining GFR. Thus, validity community-dwelling individuals is questionable. Nationally, representative data suggest management modifiable cardiovascular risk factors adults CKD far optimal. This paper explores possibility robust associations function outcomes could caused by an unknown, confounding, shared-risk extrapolates findings renal transplant donor populations support this hypothesis.

参考文章(12)
Richard J Glassock, Christopher Winearls, Ageing and the Glomerular Filtration Rate: Truths and Consequences Transactions of the American Clinical and Climatological Association. ,vol. 120, pp. 419- 428 ,(2009)
Richard J. Glassock, Christopher Winearls, The Global Burden of Chronic Kidney Disease: How Valid Are the Estimates? Nephron Clinical Practice. ,vol. 110, ,(2008) , 10.1159/000151244
Lesley A Stevens, Josef Coresh, Christopher H Schmid, Harold I Feldman, Marc Froissart, John Kusek, Jerome Rossert, Frederick Van Lente, Robert D Bruce III, Yaping Lucy Zhang, Tom Greene, Andrew S Levey, None, Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD American Journal of Kidney Diseases. ,vol. 51, pp. 395- 406 ,(2008) , 10.1053/J.AJKD.2007.11.018
Christopher G. Winearls, Richard J. Glassock, Dissecting and refining the staging of chronic kidney disease. Kidney International. ,vol. 75, pp. 1009- 1014 ,(2009) , 10.1038/KI.2009.49
Amit X. Garg, G V. Ramesh Prasad, Heather R. Thiessen-Philbrook, Li Ping, Magda Melo, Eric M. Gibney, Greg Knoll, Martin Karpinski, Chirag R. Parikh, John Gill, Leroy Storsley, Meghan Vlasschaert, Muhammad Mamdani, Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation. ,vol. 86, pp. 399- 406 ,(2008) , 10.1097/TP.0B013E31817BA9E3
Andrew S Levey, Kai-Uwe Eckardt, Yusuke Tsukamoto, Adeera Levin, Josef Coresh, Jerome Rossert, Dick DE Zeeuw, Thomas H Hostetter, Norbert Lameire, Garabed Eknoyan, None, Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney International. ,vol. 67, pp. 2089- 2100 ,(2005) , 10.1111/J.1523-1755.2005.00365.X
Andrew S Levey, Juan P Bosch, Julia Breyer Lewis, Tom Greene, Nancy Rogers, David Roth, Modification of Diet in Renal Disease Study Group*, A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation Annals of Internal Medicine. ,vol. 130, pp. 461- 470 ,(1999) , 10.7326/0003-4819-130-6-199903160-00002
Hassan N. Ibrahim, Robert Foley, LiPing Tan, Tyson Rogers, Robert F. Bailey, Hongfei Guo, Cynthia R. Gross, Arthur J. Matas, Long-Term Consequences of Kidney Donation The New England Journal of Medicine. ,vol. 360, pp. 459- 469 ,(2009) , 10.1056/NEJMOA0804883
Richard J. Glassock, Christopher Winearls, Screening for CKD with eGFR: doubts and dangers. Clinical Journal of The American Society of Nephrology. ,vol. 3, pp. 1563- 1568 ,(2008) , 10.2215/CJN.00960208
Mark J. Sarnak, Andrew S. Levey, Anton C. Schoolwerth, Josef Coresh, Bruce Culleton, L. Lee Hamm, Peter A. McCullough, Bertram L. Kasiske, Ellie Kelepouris, Michael J. Klag, Patrick Parfrey, Marc Pfeffer, Leopoldo Raij, David J. Spinosa, Peter W. Wilson, Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. ,vol. 108, pp. 2154- 2169 ,(2003) , 10.1161/01.CIR.0000095676.90936.80